Articles with "malignant solid" as a keyword



Intravoxel incoherent motion MRI for the differentiation of benign, intermediate, and malignant solid soft‐tissue tumors

Sign Up to like & get
recommendations!
Published in 2017 at "Journal of Magnetic Resonance Imaging"

DOI: 10.1002/jmri.25733

Abstract: To determine the diagnostic potential of apparent diffusion coefficient (ADC) and intravoxel incoherent motion (IVIM)‐derived parameters for the differentiation of benign, intermediate, and malignant solid soft‐tissue tumors. read more here.

Keywords: malignant solid; intravoxel incoherent; differentiation benign; incoherent motion ... See more keywords

Diagnostic utility of Cyttel-Tech in identifying meningeal metastases from malignant solid tumors: An observational study

Sign Up to like & get
recommendations!
Published in 2024 at "Medicine"

DOI: 10.1097/md.0000000000040410

Abstract: To investigate the value of circulating tumor cell (CTC) in cerebrospinal fluid (CSF) by Cyttel-Tech detection in patients with suspected leptomeningeal metastasis (LM) from malignant solid tumors. We collected CSF from 12 patients with suspected… read more here.

Keywords: ctc detection; solid tumors; malignant solid; cyttel tech ... See more keywords
Photo by nci from unsplash

Efficacy and safety of combination PD‐1/PD‐L1 checkpoint inhibitors for malignant solid tumours: A systematic review

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Cellular and Molecular Medicine"

DOI: 10.1111/jcmm.15991

Abstract: Treatment of multiple malignant solid tumours with programmed death (PD)‐1/PD ligand (PD‐L) 1 inhibitors has been reported. However, the efficacy and immune adverse effects of combination therapies are controversial. This meta‐analysis was performed with PubMed,… read more here.

Keywords: combination; safety combination; malignant solid; efficacy safety ... See more keywords

Risk factors for malignant solid pulmonary nodules: a meta-analysis

Sign Up to like & get
recommendations!
Published in 2025 at "BMC Cancer"

DOI: 10.1186/s12885-025-13702-2

Abstract: Previous studies have indicated that clinical and imaging features may assist in distinguishing between benign and malignant solid lung nodules. Yet, the specific characteristics in question continue to be debated. This meta-analysis aims to identify… read more here.

Keywords: history; analysis; malignant solid; solid pulmonary ... See more keywords

Epidemiology and clinical features of childhood malignant solid tumors in a single center in southwest China over 24 years

Sign Up to like & get
recommendations!
Published in 2025 at "BMC Pediatrics"

DOI: 10.1186/s12887-024-05360-3

Abstract: This study aims to analyze the epidemiological characteristics and clinical features of childhood malignant solid tumors in a single center in southwest China, thereby providing a reliable basis for formulating prevention and control strategies and… read more here.

Keywords: epidemiology; childhood malignant; solid tumors; malignant solid ... See more keywords

Clinical analysis of lymphoma with malignant solid tumor simultaneously: a retrospective case series

Sign Up to like & get
recommendations!
Published in 2025 at "Diagnostic Pathology"

DOI: 10.1186/s13000-025-01653-y

Abstract: This study aimed to investigate the clinical features and potential pathogenesis of lymphoma complicated with malignant solid tumors. Clinical data from 35 patients treated at Yantai Yuhuangding Hospital between January 2018 and March 2023 were… read more here.

Keywords: cancer; solid tumors; malignant solid; cell ... See more keywords

Clinical analysis of cancer associated venous thromboembolism in hospitalized patients with malignant solid tumors in real-world practices.

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2019.37.15_suppl.e14686

Abstract: e14686 Background: According to previous reports, 1% to 30% patients with malignant tumors developed venous thromboembolism (VTE) and an increased risk of VTE in hospitalized patients. However, real-world clinical analysis of VTE in Chinese hospitalized… read more here.

Keywords: hospitalized patients; malignant solid; cancer; patients malignant ... See more keywords

A phase IIa clinical trial of ABP1011T monotherapy in patients with advanced malignant solid tumors.

Sign Up to like & get
recommendations!
Published in 2025 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2025.43.16_suppl.e15145

Abstract: e15145 Background: ABP1011 T is an innovative tyrosine kinase inhibitor (TKI) that effectively inhibits EGFR, c-MET, FGFR1-4, VEGFR1-3, RET, and c-KIT. Importantly, it exhibits broader superior inhibitory activity compared to Lenvatinib and Regorafenib. In the… read more here.

Keywords: cancer; advanced malignant; solid tumors; trial ... See more keywords

Prognostic significance of HER3 in patients with malignant solid tumors

Sign Up to like & get
recommendations!
Published in 2017 at "Oncotarget"

DOI: 10.18632/oncotarget.18007

Abstract: Human epidermal growth factor receptor 3 (HER3) is closely involved in tumor progression and is an important target of therapy. To evaluate the prognostic significance of HER3 in malignant solid tumors, we searched the PUBMED,… read more here.

Keywords: solid tumors; malignant solid; significance her3; her3 ... See more keywords

Emerging Role and Mechanism of circRNAs in Pediatric Malignant Solid Tumors

Sign Up to like & get
recommendations!
Published in 2021 at "Frontiers in Genetics"

DOI: 10.3389/fgene.2021.820936

Abstract: Circular RNAs (circRNAs) are non-coding RNAs with covalent closed-loop structures and are widely distributed in eukaryotes, conserved and stable as well as tissue-specific. Malignant solid tumors pose a serious health risk to children and are… read more here.

Keywords: malignant solid; solid tumors; role mechanism; mechanism circrnas ... See more keywords

Development of Nectin4/FAP-targeted CAR-T cells secreting IL-7, CCL19, and IL-12 for malignant solid tumors

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Immunology"

DOI: 10.3389/fimmu.2022.958082

Abstract: Background Chimeric antigen receptor T (CAR-T) cell therapy has made significant advances for hematological malignancies but encounters obstacles in the treatment of solid tumors mainly due to tumor immunosuppressive microenvironment. Methods Immunohistochemistry analysis was performed… read more here.

Keywords: targeted car; fap; malignant solid; car ... See more keywords